1. Home
  2. CFR vs RGEN Comparison

CFR vs RGEN Comparison

Compare CFR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFR
  • RGEN
  • Stock Information
  • Founded
  • CFR 1868
  • RGEN 1981
  • Country
  • CFR United States
  • RGEN United States
  • Employees
  • CFR N/A
  • RGEN N/A
  • Industry
  • CFR Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • CFR Finance
  • RGEN Health Care
  • Exchange
  • CFR Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CFR 7.9B
  • RGEN 8.0B
  • IPO Year
  • CFR N/A
  • RGEN N/A
  • Fundamental
  • Price
  • CFR $130.44
  • RGEN $131.55
  • Analyst Decision
  • CFR Hold
  • RGEN Buy
  • Analyst Count
  • CFR 15
  • RGEN 12
  • Target Price
  • CFR $133.13
  • RGEN $172.67
  • AVG Volume (30 Days)
  • CFR 402.1K
  • RGEN 847.4K
  • Earning Date
  • CFR 05-01-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CFR 3.06%
  • RGEN N/A
  • EPS Growth
  • CFR 7.71
  • RGEN N/A
  • EPS
  • CFR 9.11
  • RGEN N/A
  • Revenue
  • CFR $2,038,108,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CFR $11.62
  • RGEN $13.93
  • Revenue Next Year
  • CFR $3.90
  • RGEN $14.35
  • P/E Ratio
  • CFR $14.34
  • RGEN N/A
  • Revenue Growth
  • CFR 5.45
  • RGEN 4.88
  • 52 Week Low
  • CFR $94.09
  • RGEN $102.97
  • 52 Week High
  • CFR $147.64
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CFR 67.96
  • RGEN 47.85
  • Support Level
  • CFR $121.27
  • RGEN $123.10
  • Resistance Level
  • CFR $131.82
  • RGEN $143.56
  • Average True Range (ATR)
  • CFR 2.65
  • RGEN 6.82
  • MACD
  • CFR 1.73
  • RGEN -0.65
  • Stochastic Oscillator
  • CFR 92.39
  • RGEN 33.43

About CFR Cullen/Frost Bankers Inc.

Cullen/Frost is a regional US bank with around $50 billion in assets (as of 2024 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: